自60年代开始,人们相继建立了很多有关预测病人抗肿瘤药物的敏感性和耐药性方法,如克隆形成试验,染色排除试验,放射性同位素掺入法,谷胱甘肽水平测定和P—糖蛋白测定等.琥珀酸脱氢酶抑制试验(SDI)是近年来新发展起来的一种用于体外 Since the 1960’s, many methods have been established to predict the sensitivity and drug resistance of anti-tumor drugs in patients, such as clonogenic assay, staining exclusion assay, radioisotope incorporation, glutathione level determination and P-glycoprotein Protein determination, etc. Succinate dehydrogenase inhibition test (SDI) is a newly developed in recent years for in vitro